For survival and UPR activation experiments, neuronal cultures were supplemented with a single dose of ISRIB (0.1, 0.5, or 1 μM), 4μ8C (5 or 16 µM), or GSK (0.5, 2, 4, or 8 µM), and the highest equivalent dose of DMSO as a control 1 day post transfection.
To characterize UPR activation, HEK293 cells and primary cortical neurons were treated with Thap (100 nM) alone or in combination with the UPR modulators described above [ISRIB (500 nM), GSK (2 µM), or 4µ8C (5, 16, and 50 µM), and Sephin1 (10 µM), and DMSO as a control]. Cells were harvested for Western blot (WB) analysis at different time points after treatment (from 1.5, 3, 6, 18 to 24 h).